Analysis of cephalosporins available in India: A pharmacoeconomic perspective

Authors

  • Ritesh Churihar Assistant Professor, Department of Pharmacology, Government Medical College, Ratlam, Madhya Pradesh, India https://orcid.org/0000-0002-6195-5172
  • Hemant Tanwani Associate Professor, Department of Pharmacology, Mahatma Gandhi Memorial Government Medical College, Indore, M.P. India
  • Kamayani Gupta Demonstrator, Department of Pharmacology, Mahatma Gandhi Memorial Government Medical College, Indore, M.P. India https://orcid.org/0000-0002-4745-0223

DOI:

https://doi.org/10.3126/ajms.v13i5.41249

Keywords:

Antimicrobial, Cost effectiveness, Drug resistance, Economic burdens, Pharmaceutical industry

Abstract

Background: Bacterial infections are one of the most common causes of morbidity and mortality in community and hospital settings. The acceptance of the treatment imposes heavy economic burden on the patients. Due to improper drug policy, different costly preparations of the same brand are ordered and tendered, which pose a sheer wastage of money, ultimately causing burden on tax payers.

Aims and Objectives: The present study was planned to evaluate and compare the costs of different brands of various generations of cephalosporin which may be generic or commercial in nature.

Materials and Methods: We selected commonly used drugs from different generations of cephalosporins. Cost of drugs (may be generic or commercial or of different formulations) was obtained from latest periodic manuals of Indian Drug Review (INR) and drug today and was analyzed for cost ratio, cost range, and percentage difference among brands from different pharmaceutical companies for oral and parental forms. Correlation among price variations between them was observed by data comparison.

Results: Cephalosporins were analyzed for the differences in prices. We not only found wide variation between the cost of generic and commercial preparations but also very wide price range and ratio among the same products from reputed to medium companies.

Conclusions: Our study has indicated about the wide differences in the cost of different cephalosporins which are the most commonly prescribed group of antimicrobials. If hospitals across India adopt uniform policy of prescribing cost-effective preparations (brands/generic) only, then the unnecessary economic burden can be significantly reduced.

Downloads

Download data is not yet available.
Abstract
166
PDF
400

Downloads

Published

2022-05-03

How to Cite

Churihar, R., Hemant Tanwani, & Kamayani Gupta. (2022). Analysis of cephalosporins available in India: A pharmacoeconomic perspective. Asian Journal of Medical Sciences, 13(5), 119–124. https://doi.org/10.3126/ajms.v13i5.41249

Issue

Vol. 13 No. 5 (2022)

Section

Original Articles

License

Copyright (c) 2022 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).